BIOR
Price
$2.19
Change
-$0.10 (-4.37%)
Updated
Sep 21, 6:59 PM EST
FBRX
Price
$0.79
Change
-$0.01 (-1.25%)
Updated
Sep 21, 6:59 PM EST
52 days until earnings call

Compare predictions BIOR vs FBRX

Header iconBIOR vs FBRX Comparison
Open Charts BIOR vs FBRXBanner chart's image
Biora Therapeutics
Price$2.19
Change-$0.10 (-4.37%)
Volume$41.98K
CapitalizationN/A
Forte Biosciences
Price$0.79
Change-$0.01 (-1.25%)
Volume$110.25K
CapitalizationN/A
View a ticker or compare two or three
BIOR vs FBRX Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BIOR vs. FBRX commentary
Sep 22, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOR is a Hold and FBRX is a Hold.

COMPARISON
Comparison
Sep 22, 2023
Stock price -- (BIOR: $2.19 vs. FBRX: $0.79)
Brand notoriety: BIOR and FBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIOR: 67% vs. FBRX: 173%
Market capitalization -- BIOR: $31.79M vs. FBRX: $28.91M
BIOR [@Biotechnology] is valued at $31.79M. FBRX’s [@Biotechnology] market capitalization is $28.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $424.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOR’s FA Score shows that 0 FA rating(s) are green whileFBRX’s FA Score has 0 green FA rating(s).

  • BIOR’s FA Score: 0 green, 5 red.
  • FBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BIOR and FBRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOR’s TA Score shows that 4 TA indicator(s) are bullish while FBRX’s TA Score has 4 bullish TA indicator(s).

  • BIOR’s TA Score: 4 bullish, 4 bearish.
  • FBRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, FBRX is a better buy in the short-term than BIOR.

Price Growth

BIOR (@Biotechnology) experienced а -7.59% price change this week, while FBRX (@Biotechnology) price change was -5.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.55%. For the same industry, the average monthly price growth was +25.71%, and the average quarterly price growth was +30.79%.

Reported Earning Dates

BIOR is expected to report earnings on May 15, 2023.

FBRX is expected to report earnings on Nov 13, 2023.

Industries' Descriptions

@Biotechnology (-4.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BIOR with price predictions.
OPEN
A.I.dvisor published
a Summary for FBRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BIOR($31.8M) has a higher market cap than FBRX($28.9M). FBRX YTD gains are higher at: -20.320 vs. BIOR (-33.485). FBRX has higher annual earnings (EBITDA): -24.25M vs. BIOR (-51.66M). FBRX has more cash in the bank: 30.4M vs. BIOR (26.5M). BIOR has higher revenues than FBRX: BIOR (98K) vs FBRX (0).
BIORFBRXBIOR / FBRX
Capitalization31.8M28.9M110%
EBITDA-51.66M-24.25M213%
Gain YTD-33.485-20.320165%
P/E RatioN/A0.58-
Revenue98K0-
Total Cash26.5M30.4M87%
Total Debt131MN/A-
FUNDAMENTALS RATINGS
FBRX: Fundamental Ratings
FBRX
OUTLOOK RATING
1..100
57
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
76
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIORFBRX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 17 days ago
78%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNM44.790.50
+1.13%
PNM Resources
O53.80-0.20
-0.37%
Realty Income Corp
PCT6.20-0.07
-1.12%
PureCycle Technologies
HIPO9.20-0.24
-2.54%
Hippo Holdings
XXII1.15-0.08
-6.50%
22nd Century Group

BIOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIOR has been loosely correlated with RVNC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOR jumps, then RVNC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOR
1D Price
Change %
BIOR100%
-4.37%
RVNC - BIOR
36%
Loosely correlated
-5.14%
AUPH - BIOR
34%
Loosely correlated
-0.84%
FBRX - BIOR
33%
Loosely correlated
-1.36%
MDGL - BIOR
33%
Poorly correlated
-1.18%
FATE - BIOR
32%
Poorly correlated
-2.22%
More

FBRX and

Correlation & Price change

A.I.dvisor tells us that FBRX and AXON have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBRX and AXON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
-0.40%
AXON - FBRX
31%
Poorly correlated
-0.22%
EIGR - FBRX
28%
Poorly correlated
N/A
ARRY - FBRX
28%
Poorly correlated
+0.44%
SRNEQ - FBRX
27%
Poorly correlated
-1.15%
CDTX - FBRX
27%
Poorly correlated
+8.57%
More